(63 days)
Not Found
No
The summary describes a standard MR imaging system and does not mention any AI or ML capabilities.
No
The document states that the device is a "magnetic resonance diagnostic device" used to produce images that "may assist in diagnosis," indicating a diagnostic rather than therapeutic purpose.
Yes
The "Intended Use / Indications for Use" and "Device Description" sections explicitly state that the devices "are magnetic resonance diagnostic devices" and that the images they produce "when interpreted by a trained physician, yield information that may assist in diagnosis."
No
The device description clearly outlines hardware components including a superconducting unit, radiofrequency receive chain, time-varying magnetic field system (gradients), and an integrated RF body coil, in addition to the software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD devices are used to examine specimens taken from the human body. The description of the ACHIEVA R4 devices clearly states they produce images and spectra of the internal structure of the whole body. This is an in vivo (within the living body) diagnostic method, not in vitro (in glass/outside the body).
- The intended use is based on interpreting images and spectra from the patient's body. The information is derived directly from the patient, not from analyzing a sample taken from the patient.
The ACHIEVA R4 devices are magnetic resonance diagnostic devices, which are a type of medical imaging equipment used for diagnosis based on visualizing the internal structures of the body.
N/A
Intended Use / Indications for Use
The ACHIEVA R4 1.5T and ACHIEVA R4 3.0T are magnetic resonance diagnostic devices that produce cross-sectional images, spectroscopy images and/or spectra in any orientation of the internal structure of the whole body. These images when interpreted by a trained physician, yield information that may assist in diagnosis.
In addition, the ACHIEVA R4 1.5T and ACHIEVA R4 3.0T devices provide capabilities to perform interventional procedures in the head, body and extremities, which may be facilitated by MR techniques, such as real time imaging. Such procedures must be performed with MR compatible instrumentation as selected and evaluated by the clinical user.
Product codes (comma separated list FDA assigned to the subject device)
90L--NH, 90L--NI, 90M--OS
Device Description
The next generation Philips MR platform consists of either a 1.5T or 3.0T field generating superconducting unit. The radiofrequency receive chain consists of multiple coil types delivering a simplified and unique data acquisition system. The system is configured with a time-varying magnetic field system (gradients). Additional RF transmission is provided through an integrated RF body coil. The base software for the above mentioned system will be called Release 4.
The magnetic resonance diagnostic device is used to produce cross-sectional images, spectroscopic imaging and/or spectra in any orientation of the internal structures of the whole body. These images when interpreted by a trained physician, yield information that may assist in a diagnosis. In addition, the device provides the capabilities to perform interventional procedures in the head, body and extremities, which may be facilitated by MR techniques, such as real time imaging. Such procedures must be performed with MR compatible instrumentation as selected and evaluated by the clinical user.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Magnetic Resonance
Anatomical Site
whole body, head, body and extremities
Indicated Patient Age Range
Not Found
Intended User / Care Setting
trained physician, clinical user
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K063559, K043147, K041602, K052078, K013344
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1000 Magnetic resonance diagnostic device.
(a)
Identification. A magnetic resonance diagnostic device is intended for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance. Other physical parameters derived from the images and/or spectra may also be produced. The device includes hydrogen-1 (proton) imaging, sodium-23 imaging, hydrogen-1 spectroscopy, phosphorus-31 spectroscopy, and chemical shift imaging (preserving simultaneous frequency and spatial information).(b)
Classification. Class II (special controls). A magnetic resonance imaging disposable kit intended for use with a magnetic resonance diagnostic device only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
Image /page/0/Picture/0 description: The image shows the text "Appendix 12" on the left side of the image. On the top right of the image is the text "K110151". Below that text is the text "P'1/2".
MAR 2 2 2011 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS
The following information is being submitted in accordance with the requirements of 21 CFR 807.92.
General information
| Company Name: | Philips Medical Systems Nederland BV |
|---|---|
| Address: | Veenpluis 4-6 |
| 5684 PC Best, Netherlands, | |
| Registration No.: | 3003768277 |
| Contact person: | Lynn Harmer |
| Manager, Regulatory Affairs | |
| Tel: (425) 487-7312 | |
| Fax: (425) 487-8666 | |
| Lynn.Harmer@Philips.com | |
| Date Prepared: | December 8, 2010 |
| Device (Trade) Name: | ACHIEVA R4 1.5T and ACHIEVA R4 3.0T |
| (aka Ingenia) | |
| Classification Name: | Magnetic Resonance Diagnostic Device (MRDD) |
| Regulatory Number: | 892.1000 |
| Classification: | Class II |
| Product code: | 90L--NH |
| 90L--NI | |
| 90M--OS | |
| Performance standards: | NEMA voluntary standards, FDA MR Diagnostic Device |
| Guidance, UL and IEC 60601 appropriate safety standard | |
| and/or draft standards are used. |
Predicate Device(s):
The ACHIEVA R4 1.5T and ACHIEVA R4 3.0T with enhancements are the successors of their predicate devices ACHIEVA 1.5T and ACHIEVA 3.0T MR systems Release 2.5-series (FDA references K063559, K043147, K041602, K052078 and K013344.)
Intended Use:
The ACHIEVA R4 1.5T and ACHIEVA R4 3.0T are magnetic resonance diagnostic devices that produce cross-sectional images, spectroscopy images and/or spectra in any orientation of the internal structure of the whole body. These images when interpreted by a trained physician, yield information that may assist in diagnosis. In addition, the ACHIEVA R4 1.5T and ACHIEVA R4 3.0T devices provide capabilities to perform interventional procedures in the head, body and extremities, which may be facilitated by MR techniques, such as real time imaging. Such procedures must be performed with MR compatible instrumentation as selected and evaluated by the clinical user.
1
Device description: 1
The next generation Philips MR platform consists of either a 1.5T or 3.0T field generating superconducting unit. The radiofrequency receive chain consists of multiple coil types delivering a simplified and unique data acquisition system. The system is configured with a time-varying magnetic field system (gradients). Additional RF transmission is provided through an integrated RF body coil. The base software for the above mentioned system will be called Release 4.
The magnetic resonance diagnostic device is used to produce cross-sectional images, spectroscopic imaging and/or spectra in any orientation of the internal structures of the whole body. These images when interpreted by a trained physician, yield information that may assist in a diagnosis. In addition, the device provides the capabilities to perform interventional procedures in the head, body and extremities, which may be facilitated by MR techniques, such as real time imaging. Such procedures must be performed with MR compatible instrumentation as selected and evaluated by the clinical user.
General Safety and Effectiveness 2
The ACHIEVA R4 1.5T and ACHIEVA R4 3.0T do not induce any other risks than already indicated for their predicate devices with the same safety and effectiveness.
Substantial Equivalence 8
It is the opinion of Philips Medical Systems that the Philips ACHIEVA R4 1.5T and ACHIEVA R4 3.0T are substantially equivalent to their predicate device ACHIEVA 1.5T and ACHIEVA 3.0T MR systems Release 2.5-series.
2
510(k) Contrast Agent Use Form
K110151
.
| Date | Monday, March 21, 2011 |
|---|---|
| Reviewer | Jana Delfino |
| Sponsor | Philips Medical Systems Nederland BV |
| Device | Achieva R4 1.5T and Achieva R4 3.0T MR Systems |
| IFU | "The ACHIEVA R4 1.5T and ACHIEVA R4 3.0T are magnetic resonance diagnostic |
| devices that produce cross-sectional images, spectroscopy images, and/or spectra in | |
| any orientation of the internal structure of the whole body. These images, when | |
| interpreted by a trained physician, yield information that may assist in diagnosis. |
In addition, the ACHIEVA R4 1.5T and ACHIEVA R4 3.0T devices provide capabilities
to perform interventional procedure sin the head, body and extremities, which may be
facilitated by MR techniques, such as real time imaging. Such procedures must be
performed with MR compatible instrumentation as selected and evaluated by the
clinical user." |
| Imaging
Agent Use | gadolinium-based contrast media |
| Was an outstanding drug issue letter sent after a previous submission? | No |
Predicate Device:
| 510(k) Number | K063559 |
|---|---|
| IFU | "The ACHIEVA, INTERA, and PANORMA 1.0T Release 2.5 series are magnetic |
| resonance diagnostic devices that produce cross-sectional images, spectroscopy | |
| images and/or spectra in any orientation of the internal structure of the whole body. | |
| These images when interpreted by a trained physician yield information that may | |
| assist in the diagnosis. |
In addition, these devices provide capabilities to perform interventional procedures in
the head, body and extremities, which may be facilitated by MR techniques, such as
real time imaging. Such procedures must be performed with MR compatible
instrumentation as selected and evaluated by the clinical user." |
| Imaging Agent
Use | any gadolinium-based contrast agent |
Second Predicate (if applicable):
| 510(k) Number | K043147 |
|---|---|
| IFU | "The ACHIEVA family consists of diagnostic devices that produce cross-sectional |
| images, spectroscopy images and/or spectra in any orientation of the internal | |
| structure of the whole body. These images when interpreted by a trained physician, | |
| yield information that may assist in diagnosis." | |
| Imaging Agent Use | any gadolinium-based contrast agent |
3
Third Predicate (if applicable):
| and and and and on the may and the results of the relation of the relations of the world and the first the first the first the first the first the first the first the first t
FARE OF CONSULTION AND ALL PROPERTY PATT | channel while the collection of the are a real of the large of the large to the minuted to the minuted to the may and any to the are and any to the are and any to the are and
Company of Canadian Comprehensive Concess of A 16 - NORMAL
CANTAGE OF CALLEGAL - A ACTIVITIES WALL
минальные мести с принамента принания присании мориальных принами привается при спольные привается привается по полнения по полнения по полнения по полнения по полнения по по
мену геоментин менентин и представильные по седение выставления в селовенные проведение пристементации по полнение пристемента в постивности по седение пристемента в постивно |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| THE TOUT THE OLD A LA THE THE THE THE THE | Comments of the contract and the commended to the contract and the contract of the many for the many of the many of the many of the many of the many of the many of the many o
CONTRACT LA A CLANNING AND ANNUAL
ANNALA/A/W/GAURAAAAAAAAAAAAAAA
ANNUAL AS 10 JUL 20 YEAR. |
| and the control concession of the controllers with the | Charle The Virginia Comment of Children
AND MALLANS MALE AND AND AND PARTY PLAN - L - L - L - L - L - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Comments of the company of
| AND FRONT AND OLDERS AND IN BRINGLE FORM I FORM ANDRES O |
|---|
Fourth Predicate (if applicable):
| 510(k) Number | |
|---|---|
| IFU | |
| Imaging Agent | |
| Use |
·
, ·
.
4
Image /page/4/Picture/0 description: The image shows the logo of the Department of Health & Human Services. The logo consists of a symbol on the left and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES" on the right. The symbol appears to be a stylized representation of a human figure or a caduceus, a symbol associated with medicine and healthcare.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002
Lynn Harmer Senior Manager, Regulatory Affairs . Philips Healthcare 22100 Bothell Everett Highway BOTHELL, WASHINGTON 98021
MAR 2 2 2011
Re: K110151
Trade/Device Name: Achieva R4 1.5T and Achieva R4 3.0T MR Systems Regulation Number: 21 CFR 892.1000 Regulation Name: Magnetic Resonance Diagnostic Device Regulatory Class: II Product Code: LNH Dated: January 14, 2011 Received: January 18, 2011
Dear Ms. Harmer
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of
5
medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally rinketed predicate device results in a classification for your device and thus, percorts your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to previously as ( notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its tolli fire (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely Yours.
Mary Statil
Mary S. Pastel. Sc.D. Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
6
Indication for use
KIIDISI
510(k) Number (if known):
Device Name :
ACHIEVA R4 1.5T and ACHIEVA R4 3.0T
Indication For Use :
The ACHIEVA R4 1.5T and ACHIEVA R4 3.0T are magnetic resonance diagnostic devices that produce cross-sectional images, spectroscopy images and/or spectra in any orientation of the internal structure of the whole body. These images when interpreted by a trained physician, yield information that may assist in diagnosis.
In addition, the ACHIEVA R4 1.5T and ACHIEVA R4 3.0T devices provide capabilities to perform interventional procedures in the head, body and extremities, which may be facilitated by MR techniques, such as real time imaging. Such procedures must be performed with MR compatible instrumentation as selected and evaluated by the clinical user.
Prescription Use X (Per 21 CFR 801.109)
OR Over-The-Counter Use
( PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Mary Sastl 22/11
(Division Sign-Off)
Division of Radiological Devices
Office of in Vitro Diagnostic Device Evamation and Safety